Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call

MISSISSAUGA, ON, May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024. The Company will also hold a conference call on Friday, May 10, 2024 at 8:30 ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

Cipher Pharmaceuticals (TSX:CPH) (OTCQX:CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.